BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ezzikouri S, Nourlil J, Tsukiyama-Kohara K, Kohara M, El Ossmani H, Windisch MP, Benjelloun S. Nanobodies: an unexplored opportunity to combat COVID-19. J Biomol Struct Dyn 2020;:1-3. [PMID: 33172342 DOI: 10.1080/07391102.2020.1845801] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Wu P, Yang Q, Zhao X, Liu Q, Xi J, Zhang F, He J, Yang H, Zhang C, Ma Z, Deng X, Wang Y, Chen C. A SARS-CoV-2 nanobody that can bind to the RBD region may be used for treatment in COVID-19 in animals. Research in Veterinary Science 2022. [DOI: 10.1016/j.rvsc.2022.02.003] [Reference Citation Analysis]
2 Zebardast A, Hosseini P, Hasanzadeh A, Latifi T. The role of single-domain antibodies (or nanobodies) in SARS-CoV-2 neutralization. Mol Biol Rep 2021. [PMID: 34648139 DOI: 10.1007/s11033-021-06819-7] [Reference Citation Analysis]
3 Shapiro RS. COVID-19 vaccines and nanomedicine. Int J Dermatol 2021;60:1047-52. [PMID: 34089534 DOI: 10.1111/ijd.15673] [Reference Citation Analysis]